IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
47,038,354
Share change
+819,867
Total reported value
$104,933,191
Put/Call ratio
225%
Price per share
$2.23
Number of holders
77
Value change
+$1,918,560
Number of buys
31
Number of sells
27

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q3 2017

As of 30 Sep 2017, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,038,354 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, FMR LLC, NATIXIS, Broadfin Capital, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and NORTHERN TRUST CORP. This page lists 77 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.